1. 1. Kim SS, Chang KH, Kim ST, et al. Focal lesion in the splenium of the corpus callosum in epileptic patients: antiepileptic drug toxicity? AJNR Am J Neuroradiol 20: 125-129, 1999.
2. 2. Garcia-Monco JC, Cortina IE, Ferreira E, et al. Reversible splenial lesion syndrome (RESLES): what's in a name? J Neuroimaging 21: e1-e14, 2011.
3. 3. Polster T, Hoppe M, Ebner A. Transient lesion in the splenium of the corpus callosum: three further cases in epileptic patients and a pathophysiological hypothesis. J Neurol Neurosurg Psychiatry 70: 459-463, 2001.
4. 4. Mirsattari SM, Lee DH, Jones MW, Blume WT. Transient lesion in the splenium of the corpus callosum in an epileptic patient. Neurology 60: 1838-1841, 2003.
5. 5. Jing C, Sun L, Wang Z, Chu C, Lin W. Reversible splenial lesion syndrome due to oxcarbazepine withdrawal: case report and literature review. J Int Med Res 46: 1277-1281, 2018.